148 related articles for article (PubMed ID: 37535133)
21. Placenta accreta: an immunohistological study of trophoblast populations.
Earl U; Bulmer JN; Briones A
Placenta; 1987; 8(3):273-82. PubMed ID: 2443908
[TBL] [Abstract][Full Text] [Related]
22. Animal models of the placenta accreta spectrum: current status and further perspectives.
Ma Y; Hu Y; Ma J
Front Endocrinol (Lausanne); 2023; 14():1118168. PubMed ID: 37223034
[TBL] [Abstract][Full Text] [Related]
23. The invasive phenotype of placenta accreta extravillous trophoblasts associates with loss of E-cadherin.
Duzyj CM; Buhimschi IA; Motawea H; Laky CA; Cozzini G; Zhao G; Funai EF; Buhimschi CS
Placenta; 2015 Jun; 36(6):645-51. PubMed ID: 25904157
[TBL] [Abstract][Full Text] [Related]
24. Review of MRI imaging for placenta accreta spectrum: Pathophysiologic insights, imaging signs, and recent developments.
Kapoor H; Hanaoka M; Dawkins A; Khurana A
Placenta; 2021 Jan; 104():31-39. PubMed ID: 33238233
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of classic and novel ultrasound signs of placenta accreta spectrum.
Skupski DW; Duzyj CM; Scholl J; Perez-Delboy A; Ruhstaller K; Plante LA; Hart LA; Palomares KTS; Ajemian B; Rosen T; Kinzler WL; Ananth C;
Ultrasound Obstet Gynecol; 2022 Apr; 59(4):465-473. PubMed ID: 34725869
[TBL] [Abstract][Full Text] [Related]
26. Immune cell infiltrate at the utero-placental interface is altered in placenta accreta spectrum disorders.
Hecht JL; Karumanchi SA; Shainker SA
Arch Gynecol Obstet; 2020 Feb; 301(2):499-507. PubMed ID: 32025844
[TBL] [Abstract][Full Text] [Related]
27. Indoleamine 2,3-dioxygenase and trophoblast invasion in caesarean scar pregnancy: Implications for the aetiopathogenesis of placenta accreta spectrum.
Kudo Y; Koh I; Yamazaki T; Oomori Y; Mukai Y; Sugimoto J
J Reprod Immunol; 2020 Apr; 138():103099. PubMed ID: 32050141
[TBL] [Abstract][Full Text] [Related]
28. A new methodologic approach for clinico-pathologic correlations in invasive placenta previa accreta.
Jauniaux E; Hussein AM; Zosmer N; Elbarmelgy RM; Elbarmelgy RA; Shaikh H; Burton GJ
Am J Obstet Gynecol; 2020 Apr; 222(4):379.e1-379.e11. PubMed ID: 31730756
[TBL] [Abstract][Full Text] [Related]
29. Sensitivity of antenatal ultrasound in diagnosing posterior placenta accreta spectrum disorders.
Dellapiana G; Mok T; Platt LD; Silverman NS; Han CS; Esakoff TF
J Perinat Med; 2024 Mar; 52(3):288-293. PubMed ID: 38243911
[TBL] [Abstract][Full Text] [Related]
30. Interobserver agreement on standardized ultrasound and histopathologic signs for the prenatal diagnosis of placenta accreta spectrum disorders.
Zosmer N; Jauniaux E; Bunce C; Panaiotova J; Shaikh H; Nicholaides KH
Int J Gynaecol Obstet; 2018 Mar; 140(3):326-331. PubMed ID: 29143321
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic Role of Cell-Free miRNAs in Identifying Placenta Accreta Spectrum during First-Trimester Screening.
Timofeeva AV; Fedorov IS; Suhova YV; Tarasova AM; Ezhova LS; Zabelina TM; Vasilchenko ON; Ivanets TY; Sukhikh GT
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255950
[TBL] [Abstract][Full Text] [Related]
32. Differences in regulatory T-cell and dendritic cell pattern in decidual tissue of placenta accreta/increta cases.
Schwede S; Alfer J; von Rango U
Placenta; 2014 Jun; 35(6):378-85. PubMed ID: 24725555
[TBL] [Abstract][Full Text] [Related]
33. Third-trimester ultrasound for antenatal diagnosis of placenta accreta spectrum in women with placenta previa: results from the ADoPAD study.
Fratelli N; Prefumo F; Maggi C; Cavalli C; Sciarrone A; Garofalo A; Viora E; Vergani P; Ornaghi S; Betti M; Vaglio Tessitore I; Cavaliere AF; Buongiorno S; Vidiri A; Fabbri E; Ferrazzi E; Maggi V; Cetin I; Frusca T; Ghi T; Kaihura C; Di Pasquo E; Stampalija T; Belcaro C; Quadrifoglio M; Veneziano M; Mecacci F; Simeone S; Locatelli A; Consonni S; Chianchiano N; Labate F; Cromi A; Bertucci E; Facchinetti F; Fichera A; Granata D; D'Antonio F; Foti F; Avagliano L; Bulfamante GP; Calì G;
Ultrasound Obstet Gynecol; 2022 Sep; 60(3):381-389. PubMed ID: 35247287
[TBL] [Abstract][Full Text] [Related]
34. Validation of a scoring system for prediction of obstetric complications in placenta accreta spectrum disorders.
Zheng W; Zhang H; Ma J; Dou R; Zhao X; Yan J; Yang H
J Matern Fetal Neonatal Med; 2022 Nov; 35(21):4149-4155. PubMed ID: 33685330
[TBL] [Abstract][Full Text] [Related]
35. Ultrasound scoring system for prenatal diagnosis of placenta accreta spectrum.
Zhang J; Li H; Feng D; Wu J; Wang Z; Feng F
BMC Pregnancy Childbirth; 2023 Aug; 23(1):569. PubMed ID: 37550654
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic accuracy of ultrasound in detecting the severity of abnormally invasive placentation: a systematic review and meta-analysis.
Pagani G; Cali G; Acharya G; Trisch IT; Palacios-Jaraquemada J; Familiari A; Buca D; Manzoli L; Flacco ME; Fanfani F; Liberati M; Scambia G; D'antonio F
Acta Obstet Gynecol Scand; 2018 Jan; 97(1):25-37. PubMed ID: 28963728
[TBL] [Abstract][Full Text] [Related]
37. Enhanced expression of αVβ3 integrin in villus and extravillous trophoblasts of placenta accreta.
Weitzner O; Seraya-Bareket C; Biron-Shental T; Fishamn A; Yagur Y; Tzadikevitch-Geffen K; Farladansky-Gershnabel S; Kidron D; Ellis M; Ashur-Fabian O
Arch Gynecol Obstet; 2021 May; 303(5):1175-1183. PubMed ID: 33112993
[TBL] [Abstract][Full Text] [Related]
38. Possible Association between Cathepsin V and the Development of Placenta Accreta Spectrum Disorders.
Matsukawa S; Sumigama S; Kotani T; Wang J; Miki R; Moriyama Y; Nakano T; Mano Y; Tsuda H; Tamakoshi K; Kikkawa F
Gynecol Obstet Invest; 2019; 84(4):396-406. PubMed ID: 30759440
[TBL] [Abstract][Full Text] [Related]
39. Accreta complicating complete placenta previa is characterized by reduced systemic levels of vascular endothelial growth factor and by epithelial-to-mesenchymal transition of the invasive trophoblast.
Wehrum MJ; Buhimschi IA; Salafia C; Thung S; Bahtiyar MO; Werner EF; Campbell KH; Laky C; Sfakianaki AK; Zhao G; Funai EF; Buhimschi CS
Am J Obstet Gynecol; 2011 May; 204(5):411.e1-411.e11. PubMed ID: 21316642
[TBL] [Abstract][Full Text] [Related]
40. Correlation of clinical outcomes with the application of the 2020 consensus panel on histological classification for Placenta Accreta Spectrum (PAS).
Munoz JL; Pfeiffer AF; Ramsey PS
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):10044-10048. PubMed ID: 35703727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
